Fentanyl Patch Cases Consolidated in Single Federal Court
A recent decision by the U.S. Judicial Panel on Multidistrict Litigation has decided to centralize 22 different lawsuits against Watson Pharmaceuticals in the Northern District of Illinois. These cases all stem from allegations that a product manufactured by Watson - a transdermal pain medication known as a fentanyl patch - is defective and has caused severe injuries and death.
Originally, Watson had hoped the Judicial Panel would have consolidated all fentanyl patch cases, including cases involving other manufacturers - such as ALZA Corp, Johnson & Johnson and Mylan ...






